8-KFiled Sep 8, 8:00 PM ET

OS Therapies Inc. Elects Directors, Approves Amended Incentive Plan

$OSTX · OS Therapies Inc

Research Summary

AI-generated summary of this SEC filing

Updated

OS Therapies Inc. Elects Directors, Approves Amended Incentive Plan

What Happened
OS Therapies Inc. (OSTX) filed an 8-K reporting results from its September 9, 2026 annual meeting. Stockholders elected six directors to serve through the 2027 annual meeting and approved an Amended and Restated 2023 Incentive Compensation Plan. Shareholders also ratified MaloneBailey, LLP as the company’s independent registered public accounting firm for fiscal 2026. The full text of the amended plan is filed as Exhibit 10.1 and was summarized in the company’s July 24, 2026 proxy statement.

Key Details

  • Meeting quorum: holders of 26,059,902 of 46,205,601 shares entitled to vote were present in person or by proxy.
  • Director elections (For / Withheld / Broker Non-Votes):
    • Paul A. Romness: 7,336,591 / 67,922 / 18,655,389
    • John Ciccio: 7,110,791 / 293,722 / 18,655,389
    • Craig Eagle: 7,336,860 / 67,653 / 18,655,389
    • Avril McKean Dieser: 7,336,889 / 67,624 / 18,655,389
    • Olivier R. Jarry: 7,336,925 / 67,588 / 18,655,389
    • Theodore F. Search: 7,336,522 / 67,991 / 18,655,389
  • Amended and Restated 2023 Incentive Compensation Plan vote: For 4,515,930; Against 885,667; Abstain 2,002,913; Broker Non-Votes 18,655,392.
  • Auditor ratification vote: MaloneBailey, LLP ratified with For 25,689,179; Against 340,644; Abstain 30,079.

Why It Matters

  • Board continuity: Re-election of the six nominees keeps the current board in place through the next annual meeting, which maintains management and strategic continuity.
  • Compensation & potential dilution: Approval of the amended incentive plan permits the company to grant stock-based awards under the new plan terms (see Exhibit 10.1 and the July 24, 2026 proxy for material terms). Such plans can affect executive pay and potential share dilution — factors investors watch when assessing equity value.
  • Governance confirmation: Ratifying the auditor completes a key governance step for fiscal 2026 reporting.
  • Note on broker non-votes: Large broker non-vote counts on the director and plan proposals indicate many shares held in street name were not voted on these items, which can affect the voting picture for matters requiring only votes cast in person or by proxy.